Sanofi Showcases Expansive Respiratory Innovation and Scientific Leadership at ATS 2025 with Robust Clinical Data from Dupixent and Immunology Pipeline Sanofi is poised to make a major impact at the…
Amgen Posts Strong First Quarter 2025 Financial Results, Driven by Robust Product Demand and Strategic Launches Amgen Inc. (NASDAQ: AMGN) reported its financial results for the first quarter of 2025,…
AstraZeneca’s Breztri Achieves Primary Endpoints in KALOS and LOGOS Phase III Trials, Marking a Significant Advance in the Treatment of Uncontrolled Asthma AstraZeneca announced encouraging high-level results from its pivotal…
BOTOX® Cosmetic Expands Commitment to Female Empowerment with The Confidence Project for Women Entrepreneurs In a bold move to champion female entrepreneurship and narrow the persistent confidence gap between men…
Eli Lilly Reports Strong Q1 2025 Financial Results, Driven by Surging Demand for Mounjaro and Zepbound, While Advancing Pipeline Innovations Eli Lilly and Company (NYSE: LLY) has delivered a robust…
Vaccine Study Shows Fewer Side Effects with PharmaJet Needle-Free Delivery PharmaJet®, a company committed to advancing the performance, safety, and effectiveness of injectable vaccines and therapies through innovative needle-free injection…
AI-Driven HSS Study Identifies Risk Factors for Severe Pain After Knee Replacement At the 50th Annual Meeting of the American Society of Regional Anesthesia and Pain Medicine (ASRA), a groundbreaking…
PrimaryOne Health and AndHealth Cut Ribbon on New Retail & Specialty Pharmacy to Enhance Community Medication Access PrimaryOne Health, in partnership with AndHealth, proudly celebrated the grand opening of its…
New SURPASS-3 Data Links Tirzepatide to Muscle Composition Changes in Type 2 Diabetes In an increasingly dynamic and rapidly evolving field of metabolic disease management, the nuanced effects of weight…
Bio-Rad Announces Financial Results for the First Quarter of 2025 Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics, released its financial results for the…
Crown Bioscience and NEXT Oncology Expand Strategic Partnership In a significant development that reinforces their shared vision for transforming cancer research and drug development, Crown Bioscience, a global contract research…
Genmab to Submit sBLA to FDA for Epcoritamab Combo in Relapsed/Refractory Follicular Lymphoma Genmab A/S, a leading international biotechnology company specializing in the development of antibody therapeutics for the treatment…